![Inappropriate prescription of corticosteroid therapy during inflammatory ileo‐colitis revealing disseminated tuberculosis with digestive involvement: Two case reports - Razafindrazoto - 2021 - Clinical Case Reports - Wiley Online Library Inappropriate prescription of corticosteroid therapy during inflammatory ileo‐colitis revealing disseminated tuberculosis with digestive involvement: Two case reports - Razafindrazoto - 2021 - Clinical Case Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/93a92b11-cae4-4bf0-ad97-138c7f1812cf/ccr34215-fig-0002-m.jpg)
Inappropriate prescription of corticosteroid therapy during inflammatory ileo‐colitis revealing disseminated tuberculosis with digestive involvement: Two case reports - Razafindrazoto - 2021 - Clinical Case Reports - Wiley Online Library
![Children | Free Full-Text | Acceptability of Prednisolone in an Open-Label Randomised Cross-Over Study—Focus on Formulation in Children Children | Free Full-Text | Acceptability of Prednisolone in an Open-Label Randomised Cross-Over Study—Focus on Formulation in Children](https://www.mdpi.com/children/children-09-01236/article_deploy/html/images/children-09-01236-g004.png)
Children | Free Full-Text | Acceptability of Prednisolone in an Open-Label Randomised Cross-Over Study—Focus on Formulation in Children
![In Vitro Antioxidant, Anti-inflammatory, and In Vivo Anticolitis Effects of Combretin A and Combretin B on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice In Vitro Antioxidant, Anti-inflammatory, and In Vivo Anticolitis Effects of Combretin A and Combretin B on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice](https://static.hindawi.com/articles/grp/volume-2020/4253174/figures/4253174.fig.001a.jpg)
In Vitro Antioxidant, Anti-inflammatory, and In Vivo Anticolitis Effects of Combretin A and Combretin B on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice
![Pharmacokinetics of prednisolone in children: an open-label, randomised, two-treatment cross-over trial investigating the bioequivalence of different prednisolone formulations in children with airway disease | BMJ Paediatrics Open Pharmacokinetics of prednisolone in children: an open-label, randomised, two-treatment cross-over trial investigating the bioequivalence of different prednisolone formulations in children with airway disease | BMJ Paediatrics Open](https://bmjpaedsopen.bmj.com/content/bmjpo/3/1/e000520/F1.large.jpg)
Pharmacokinetics of prednisolone in children: an open-label, randomised, two-treatment cross-over trial investigating the bioequivalence of different prednisolone formulations in children with airway disease | BMJ Paediatrics Open
![Pharmacokinetics of prednisolone in children: an open-label, randomised, two-treatment cross-over trial investigating the bioequivalence of different prednisolone formulations in children with airway disease | BMJ Paediatrics Open Pharmacokinetics of prednisolone in children: an open-label, randomised, two-treatment cross-over trial investigating the bioequivalence of different prednisolone formulations in children with airway disease | BMJ Paediatrics Open](https://bmjpaedsopen.bmj.com/content/bmjpo/3/1/e000520/F2.large.jpg)